Laura Samples, MD
@LauraSamplesMD
Followers
90
Following
107
Media
2
Statuses
10
Heme-Onc fellow @Fredhutch and @UW. All views are my own.
Seattle, WA
Joined May 2023
The @US_FDA approves @bmsnews lisocabtagene maraleucel for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Kudos to all investigators and sites involved! https://t.co/wqQ6N6Sluc
@mshadman
news.bms.com
Breyanzi offers a personalized treatment option delivered as a one-time infusion that provides deep and durable responses for patients with relapsed or refractory CLL or SLL who have historically had...
1
27
70
Thank you to @ASH_hematology and all of our collaborators who made this project possible! So happy to see our results published in @BloodAdvances!
Combination treatments with two or more blood pressure drugs can significantly reduce blood pressure in patients taking ibrutinib, according to a new study in @BloodAdvances. Read more: https://t.co/ExbYPTeSmF
@mshadman @LauraSamplesMD @fredhutch
0
1
7
I am, of course, biased, but I loved our first "Seattle Cellular Therapy Summit." Enjoyed working with @KrishPatelMD ' @binayshah and the @btfoundation staff. Thanks to our great speakers, attendees, and supporters. Save the date for our next summit on 8/16-17/24!
0
3
20
Breast cancer - most common cancer in sub-Saharan Africa - and BBI’s Dr. Manoj Menon @FredHutch at @ASCO meeting sharing insights on molecular testing on breast cancer tumors from Uganda Cancer Institute patients. https://t.co/GNYrskUnd3
1
4
9
My colleague @HibaMKhanMD gave a meaningful talk @ASCO this morning, highlighting a higher risk for mortality in patients who experience adverse financial events. It's also interesting to see the risk of death among common cancer types.
1
5
12
Thanks to all who collaborated on this project! Our ASCO poster on CAR-T outcomes among R/R patients with Burkitts highlights a need for new strategies to treat this rare disease.
5
6
33